Visionary Metals New Recommendation

Free Investment Blog  invest at your own risk.


Free stock research, invest at your own risk.


Free Investment blog Invest at your own risk.

New rating system initiated. 

 (1-5)  1 lowest risk  5 

higest risk.

Rating for Visionary Metals  5+ extremely risky.


15 July 2023 $ 0.075 CDN  VIZ.V


Recently changed name from Visionary Gold to Visionary Metals and the focus of the company is EV metals. Starting with a focus on their new Nickle discovery of:

44.5 metres ("m") of 0.23% nickel, 0.01% cobalt (from 87 m depth), including 17.0 m of 0.42% nickel, 0.023% cobalt and anomalous levels of precious metals


1. 80 square km undrilled greenstone belt. Lots of potential but very Risky.

There have been no new nickle discoverys in Eastern North America since the 1990's.


2. Wes Adams CEO is hinting that this could be a " New Nickel District."

I suggest watching this recent video.

2nd company featured.


https://finance.yahoo.com/news/power-play-market-herald-releases-183000082.html


3. Normally you look for metals where they have been found before so this is higest risk, highest reward opportunity. 


4. Wes Adams put  over $474,000 of his own money in it recently and is biggest shareholder with 28.7% interest if all warrants are issued. 


5.  A drilling program is set to start soon and a regional exploration program over the next year on their large property as well.











Comments

Post a Comment

Popular posts from this blog

First Stock Pick Oncolytics Biotech

 New Blog starting on 16 September 2022. Plan is to feature ONLY 5 stocks per year, that will have at least a possibility to double in a year. We will be looking for undervalued and turnaround situations with ability to provide good Gains for investors. Please invest at your own risk We are investors with experience,  but as always there are no Guarantees. So it will be easy to follow because we will be only covering a few stocks per year. Our First Stock Pick is Oncolytics Biotech  ONCY on NASDAQ and ONC on Toronto exchange.  Current Price is 1.72 CDN and 1.31 US. We believe that Oncolytics Biotech will be bought by Roche or Pfizer in less than a year and possibly within 6 months or less. A bidding war between the two big Pharmas is  possible. See next message for investment thesis. 
Read more

Our Third Stock Pick Geodrill

 Free stock investing Blog.  Invest at your own risk 19 Sept 2022 Our third Stock pick Geodrill is yet another potential buyout candidate over the next 12 months. GEO .TO or GEODF on OCTQX  Closing Price  $2.50 CDN or 1.90 US 1. Geodrill is a potential takeover target,. The CEO has made it clear he's ready to retire but no buyer yet and CEO is doing an excellent job to continue growing the company and paying a dividend now as well. CEO David Harper started the company with one drill rig and one contract in 1998. 2.  Recent youtube video by Radius Research will give you a lot of info on the company.  https://www.youtube.com/watch?v=43Ofg-_DpPg 3. Geodrill uplisted recently to the 2nd tier OTCQX  making it easier for US investors to purchase this interesting small cap company. It looked like it was going for a nice runup then the market crash happened.  I think this presents a good buying opportunity. 4.  Geodrill is a leading exploration drill...
Read more

July 15 2023 Updates

 Due to an extremely busy life and work schedule. I was unable to continue this Blog. I'm giving it another shot and will try to keep it going.  I had 2 other people helping me but they were unable to contribute as well. So the analysis will be I instead of "we" for the near future anyway. I may try to recruit other help. The idea is to pick 5 stocks in any year period no more, perhaps less. That have the potential to double.  In my stock investing I have seen many stocks double, everyone is focused on multi baggers. To me it seems more prudent to look for doubles and the sell half or all or hold if things look very promising otherwise look for a new opportunity. My focus will be Canadian small cap stocks and  possibility of microcaps as well, but will consider all opportunities. Adding a new rating system to each stock as well. 1 to 5, 1 being one I consider less risky and 5 being highest risk.  ONC.TO  my first feature pick has more than doubled since las...
Read more